Manufacturing High Quality and Purity Antibody–Drug Conjugates
Credit: iStock
Want to share this FREE webinar with a colleague?
Fill out the form below and we'll send your colleague an invitation to the "Manufacturing High Quality and Purity Antibody–Drug Conjugates" event.
Antibody–drug conjugates (ADCs) represent a groundbreaking approach to targeted therapeutics, however their manufacture requires specialized strategies to overcome hurdles in potency testing, product purity and regulatory compliance.
This webinar highlights key strategies for advancing ADC manufacturing, featuring expert insights and best practices for overcoming common challenges.
Download this webinar to discover:
- Proven strategies to maintain ADC potency and purity at scale
- The role of cGMP-grade reagents in consistent, high-quality conjugation
- Regulatory insights to streamline ADC production and launch readiness
Brought to you by
Have a question about our online events and webinars?
Get in touch here.
Now Available on Demand!
Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
Experiencing issues viewing the form? Click here to access an alternate version
